NextVivo Analysis: $8M Raised
What is NextVivo?
Immune organoid technology for drug development
HQ Country
Palo Alto, United States
Employees
1-10
Founded
2021
HQ State/Province
California
Funding Category
Seed
HQ Full Address
3160 Porter Dr, Palo Alto, California 94304, United States
Product Features & Capabilities
- 3D organoid models of human tissues
- Immune competent human-derived models for drug testing
- Therapeutic applications for cancer, infections, and autoimmune disorders
